OpenBilldrug price receipt

NADAC week of 2026-10-14

PACERONE 200 MG TABLET

FDA nonproprietary name: amiodarone hydrochloride

For 30 tablets

Pharmacies pay

$3.75 filed

30 × $0.12488 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2025-11-19 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$59.65 filed

30 × $1.98836 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

15.9× estimated

Medicare paid 15.9× what pharmacies pay.

Part D averages every strength and form sold under “Pacerone” / “Amiodarone HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2025-11-19 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$9.31 estimated

$3.75 + $0.56 (15%) + $5.00 fee per fill = $9.31

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2025-11-19 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

PACERONE 200 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as amiodarone hydrochloride, under the trade name “Pacerone”.

FDA gives its dosage form as tablet and its route as oral.

The labeler, the company named on the label, is Upsher-Smith Laboratories, LLC.

FDA’s Established Pharmacologic Class for it is Antiarrhythmic.

The NADAC file of 2026-10-14 prices it under 4 NDCs (National Drug Codes); the FDA directory lists 3 of them.

NADAC classes it in its brand rate-setting class B-ANDA, and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $3.75 for 30 tablets (30 × $0.12488 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2025-11-19. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 4, carried forward from the previous file; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

The NADAC of all 4 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: those prices took effect on 2025-11-19. The file is new; the price is not.

NADAC also lists, on the row of its brand NDCs, what pharmacies pay for the generic equivalent, a different product: $0.12179 per EA filed.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

All 4 NDCs

Other strengths, forms and brands

5 other products in the NADAC file share the FDA nonproprietary name amiodarone hydrochloride with PACERONE 200 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
AMIODARONE 150 MG/3 ML VIAL
generic · injection, solution
$0.52115 per ML filed
eff. 2026-07-22
$0.64 per ML derived
Part B limit 2026 Q4
AMIODARONE HCL 100 MG TABLET
generic · tablet
$0.37584 per EA filed
eff. 2026-09-23
$0.41637 per EA filed
Part D 2024 average
AMIODARONE HCL 200 MG TABLET
generic · tablet
$0.12179 per EA filed
eff. 2026-09-23
$0.41637 per EA filed
Part D 2024 average
AMIODARONE HCL 400 MG TABLET
generic · tablet
$0.49957 per EA filed
eff. 2026-09-23
$0.41637 per EA filed
Part D 2024 average
PACERONE 100 MG TABLET
brand · tablet
$0.7762 per EA filed
eff. 2026-06-17
$1.98836 per EA filed
Part D 2024 average
PACERONE 200 MG TABLET this page
brand · tablet
$0.12488 per EA filed
eff. 2025-11-19
$1.98836 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. between 2025-11-19 and 2026-09-23 (4 dates) · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

Compared with its class

The middle of its 4 NDCs’ NADAC prices is $0.12488 per EA filed.

Of the 43 other products in FDA’s Antiarrhythmic class priced per EA, 36 have a higher middle NADAC price and 7 a lower one. The one in the middle is PROPAFENONE HCL 300 MG TAB, at $0.38802 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2025-11-19, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $59.65 for 30 tablets, at an average of $1.98836 per EA in 2024 (2024-01-01 to 2024-12-31) for “Pacerone” and “Amiodarone HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 31,143 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for PACERONE 200 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Pacerone / Amiodarone HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.